Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Ogdensburg › NPI 1891753034
Hospital

Claxton-Hepburn Medical Center

Claxton-Hepburn Medical Center was paid $18.07M by Medicaid between Jan 2018 and Nov 2024, across 232 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.

33Billing provider infoCLAXTON-HEPBURN MEDICAL CENTER
OGDENSBURG, NY 13669
33aNPI1891753034assigned 05/03/2006
33bProvider typePsychiatric Hospital
28Total paid$18.07M
24GClaims364,941
24DCodes billed232
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other Psychiatric Hospital providers in New York

Rank by total paid#1 of 14
Median peer was paid$317K
This provider vs. median57×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20182,355$103K
201920,529$852K
202062,427$2.85M
202185,239$3.42M
202283,524$5.91M
202372,062$3.44M
2024incomplete38,805$1.50M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 18% 34,716 31,644 $3.27M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 7.7% 13,382 12,587 $1.39M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 6.1% 6,406 6,082 $1.10M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 4.7% 4,191 1,916 $857K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.7% 5,689 5,349 $677K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.5% 4,818 4,537 $632K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.5% 11,328 9,298 $624K
96361 Intravenous infusion, hydration; each additional hour 3.4% 2,418 2,166 $614K
36415 Collection of venous blood by venipuncture 3.2% 12,714 9,781 $579K
80053 Comprehensive metabolic panel 3.2% 20,041 17,822 $572K
90834 Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient 2.4% 3,225 2,118 $428K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.0% 7,729 6,993 $370K
220 more codes
G0463 Hospital outpatient clinic visit for assessment and management of a patient 1.7% 3,203 $313K
90832 Psychotherapy session, about 30 minutes 1.6% 3,044 $286K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.5% 1,142 $267K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.4% 1,581 $251K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 899 $239K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 1,843 $225K
42820 Tonsillectomy and adenoidectomy; younger than age 12 1.2% 218 $224K
70450 Computed tomography, head or brain; without contrast material 1.2% 769 $223K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.2% 2,189 $209K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.1% 4,028 $195K
99232 Hospital visit by a doctor, follow-up day 1.1% 7,054 $194K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.1% 2,947 $193K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.0% 1,682 $184K
90837 Psychotherapy session, about an hour <1% 801 $167K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,101 $149K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,427 $143K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 4,313 $129K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 8,530 $128K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 1,317 $128K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 1,502 $127K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,461 $120K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 641 $112K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 1,099 $107K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,518 $104K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 1,109 $101K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 1,197 $100K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 1,013 $100K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,414 $92K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,175 $82K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,176 $77K
90792 Psychiatric diagnostic evaluation with medical services <1% 877 $77K
99203 Doctor's office visit, new patient (routine) <1% 638 $75K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 450 $74K
90791 Psychiatric diagnostic evaluation <1% 446 $72K
80061 Lipid panel <1% 8,348 $70K
80050 General health panel <1% 1,212 $70K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,157 $66K
90686 <1% 2,097 $65K
80048 Basic metabolic panel (calcium, ionized) <1% 2,129 $61K
84443 Thyroid stimulating hormone (TSH) <1% 7,952 $57K
87486 <1% 977 $48K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 21,032 $45K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 298 $42K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 53 $38K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,442 $38K
99239 Hospital discharge day management, more than 30 minutes <1% 858 $37K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 293 $34K
97162 <1% 308 $33K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 251 $32K
83036 Hemoglobin; glycosylated (A1C) <1% 5,378 $30K
99215 Doctor's office visit, returning patient (complex) <1% 191 $29K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 206 $28K
99401 <1% 885 $27K
G0444 Annual depression screening, 5 to 15 minutes <1% 1,465 $27K
99442 <1% 263 $25K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 1,411 $24K
82728 <1% 2,346 $23K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 3,762 $23K
88142 <1% 1,021 $23K
84439 <1% 3,150 $22K
99406 <1% 733 $21K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,038 $21K
71275 Computed tomographic angiography, chest, with contrast material <1% 68 $21K
82607 <1% 2,002 $20K
90836 <1% 240 $19K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 12 $19K
S5161 Emergency response system; service fee, per month (excludes installation and testing) <1% 1,748 $19K
87581 <1% 977 $19K
90715 <1% 604 $18K
99204 Doctor's office visit, new patient (more involved) <1% 146 $18K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 839 $17K
87088 <1% 3,917 $16K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 787 $15K
90670 <1% 591 $15K
76830 Ultrasound, transvaginal <1% 361 $14K
71250 <1% 179 $13K
84153 <1% 948 $13K
86703 <1% 915 $13K
11043 <1% 123 $13K
81001 <1% 7,787 $13K
71046 Radiologic examination, chest; 2 views <1% 2,549 $12K
90648 <1% 599 $11K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 66 $11K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 2,538 $11K
83655 <1% 639 $10K
94060 <1% 108 $10K
83540 <1% 2,839 $10K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,369 $10K
83550 <1% 2,839 $10K
82803 <1% 245 $9K
99441 <1% 73 $8K
73564 <1% 849 $8K
90633 <1% 387 $8K
86850 <1% 187 $8K
90651 <1% 144 $8K
93000 <1% 1,649 $7K
82043 <1% 1,888 $7K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 2,619 $7K
59025 Fetal non-stress test <1% 90 $6K
90734 <1% 240 $6K
87076 <1% 1,643 $6K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 2,498 $6K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 319 $6K
84703 <1% 2,803 $6K
84702 <1% 595 $6K
90723 <1% 341 $5K
85610 <1% 1,941 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 652 $5K
86803 <1% 684 $5K
83735 <1% 1,815 $5K
87186 <1% 1,644 $5K
86900 <1% 257 $3K
99443 <1% 39 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 27 $3K
83020 <1% 272 $3K
99205 Prolong outpt/office vis <1% 14 $3K
81015 <1% 4,456 $3K
99188 <1% 42 $3K
86140 <1% 1,079 $3K
36591 <1% 86 $3K
86141 <1% 411 $3K
87070 <1% 709 $2K
76641 <1% 81 $2K
J3490 Unclassified drugs <1% 350 $2K
86901 <1% 187 $2K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 79 $2K
86618 <1% 176 $2K
86580 <1% 84 $2K
85652 <1% 1,171 $2K
71045 Radiologic examination, chest; single view <1% 1,249 $2K
72110 <1% 131 $2K
00170 Anesthesia for intraoral procedures, including biopsy <1% 18 $2K
90461 <1% 1,100 $2K
90707 <1% 90 $2K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 52 $2K
G0378 Hospital observation service, per hour <1% 23 $2K
96375 Therapeutic injection; each additional sequential IV push <1% 2,157 $2K
73030 <1% 232 $2K
82746 <1% 153 $2K
80076 <1% 229 $1K
85730 <1% 1,163 $1K
90681 <1% 84 $1K
97161 <1% 13 $1K
87481 <1% 70 $1K
73630 <1% 311 $1K
82784 <1% 112 $1K
84484 <1% 1,859 $1K
90716 <1% 54 $1K
86038 <1% 226 $1K
83690 <1% 1,943 $1K
96367 <1% 32 $1K
71271 <1% 51 $920.96
73610 <1% 234 $894.27
86780 <1% 86 $848.69
94726 <1% 40 $843.28
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 1,460 $842.11
85014 <1% 295 $817.42
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 71 $769.75
J7030 Infusion, normal saline solution , 1000 cc <1% 1,081 $617.74
82550 <1% 1,091 $600.84
81002 <1% 956 $586.21
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 578 $505.56
G0442 Annual alcohol misuse screening, 5 to 15 minutes <1% 13 $481.55
J7120 Ringers lactate infusion, up to 1000 cc <1% 352 $467.43
84480 <1% 77 $441.67
87086 Culture, bacterial; quantitative colony count, urine <1% 175 $422.52
94729 <1% 40 $340.25
J2704 Injection, propofol, 10 mg <1% 590 $334.10
84100 <1% 107 $326.18
85379 <1% 205 $305.86
90696 <1% 17 $303.45
83519 <1% 140 $297.63
86430 <1% 77 $293.94
87634 <1% 129 $275.49
G0435 Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening <1% 21 $275.08
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 793 $247.40
93017 <1% 12 $210.00
74018 <1% 42 $208.80
86376 <1% 12 $203.70
83605 <1% 476 $184.50
73110 <1% 62 $179.22
73502 <1% 29 $157.47
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 425 $153.67
87040 <1% 260 $143.74
82553 <1% 537 $133.03
94761 <1% 848 $130.79
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 1,757 $130.35
87650 <1% 380 $128.52
86329 <1% 12 $128.35
82785 <1% 13 $124.27
82565 <1% 25 $111.81
86617 <1% 19 $107.15
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 258 $96.59
82150 <1% 162 $92.81
73130 <1% 65 $87.58
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 996 $84.93
82787 <1% 12 $68.94
82947 <1% 22 $43.03
J0690 Injection, cefazolin sodium, 500 mg <1% 25 $42.80
82977 <1% 12 $40.24
J2270 Injection, morphine sulfate, up to 10 mg <1% 320 $39.16
83615 <1% 18 $38.49
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 14 $33.10
82948 <1% 114 $31.41
J1450 Injection fluconazole, 200 mg <1% 86 $23.92
J1756 Injection, iron sucrose, 1 mg <1% 60 $21.27
J7050 Infusion, normal saline solution, 250 cc <1% 49 $15.10
J3010 Injection, fentanyl citrate, 0.1 mg <1% 468 $13.62
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 183 $10.50
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 71 $9.34
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 220 $1.54
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 27 $1.50
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) <1% 332 $0.01
99173 0% 17 $0.00
90472 Immunization administration, each additional vaccine (list separately) 0% 33 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 14 $0.00
88300 0% 61 $0.00
J1170 Injection, hydromorphone, up to 4 mg 0% 31 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 0% 35 $0.00
J2060 Injection, lorazepam, 2 mg 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBLOOM, ROB (CFO)